Every signal you have, genetics, wearables, labs, microbiome, environment and lifestyle, fused into one profile that returns actionable, AI-driven, evidence-checked guidance. Private by design.
We have not found a product that unifies a person's biology this way. VitaCrypt does, built to fold in any health signal and grow over time, and every recommendation cites a real source retrieved live, so guidance reads the whole picture against your genotype and environment. Privacy is the trust layer that makes centralizing this data acceptable, not the pitch.
People generate more health data than ever, genetic reports, wearables, blood panels, microbiome kits, even the air they breathe, but it lives in a dozen disconnected apps that each see one fragment. We have not found a product that fuses it into a single profile and reads it as a whole. VitaCrypt does: one unified profile that turns scattered signals into actionable, evidence-checked guidance, and is private by design so the data never has to be exposed to be understood.
Consumers already pay for DNA kits, wearables and lab panels. The signals are everywhere; we have not found a product that unifies them into one coherent health picture.
"You slept 6 hours, you walked 8k steps" is not guidance. Value comes from reading the whole profile together, against your genetics and your environment.
People will only centralize their most sensitive data if exposure is off the table. Private-by-design architecture is what makes the unified profile possible at all.
Consumer health and longevity is one of the fastest-growing spaces in tech. The money is racing in; the unified, trustworthy profile is the gap still open.
This product was not buildable a few years ago. Enough people now carry genetic, wearable and lab data to make a unified profile meaningful; the category has serious capital; and the privacy technology that lets a person trust one app with all of it finally shipped. The gap is that we have not found these put together.
The competitive heat is real: Function Health sued Superpower in 2025 over advertising, a sign of how contested this category has become. We do not compete on drawing blood. We compete on the layer above it: unification, evidence-checked guidance and privacy that no fragmented, plaintext-holding competitor can match.
Any one of these is a feature. Together they are hard to copy: a fragmented competitor cannot retro-fit a unified profile, a generic one cannot match guidance read against your whole biology, and none of it earns trust without privacy built in from the start.
The one position a giant structurally will not take is independence: VitaCrypt is built so your profile never has to land in a single AI company's cloud to be understood. That is the gap their business model cannot close without ceasing to be itself.
The full four-pillar deep dive → Cryptography and threat model →
A working product, pre-launch, and honest about it: no revenue, no users yet. But the product already ingests real genetic, environmental, survey and lifestyle data into one profile and returns recommendations classified through a three-tier evidence router with a software-enforced clinical boundary, each cited to real retrieved literature. What the round completes is depth and production hardening. The list below is deliberately conservative.
| Capability | What it actually does today | Status |
|---|---|---|
| Genetics | 23andMe raw upload, SNP parsing, curated risk markers, health score | Live, E2E |
| Environment | Live air quality, PM2.5, weather, geo-keyed to the user | Live |
| Evidence router | Three-tier classification, per-paper concordance, composite confidence indicator | Live, unit-tested |
| Clinical boundary | Clinical insights withheld server-side, warm handoff to a clinician | Live, software-enforced |
| CPIC reference | CYP2C9 descriptive pharmacogenomic reference | Live |
| Surveys / lifestyle | Lifestyle, context and goal check-ins; self-reported wellbeing as optimization signals, not clinical screeners | Live |
| Recommendations | Cited next actions (real PMIDs), source badges, a concrete tiny-habit per tip | Live |
| Health-score trend | Real dated history, charted from actual scores | Live |
| Labs | OCR and biomarker parsing wired; awaiting a lab file to populate | Wired |
| Wearables | Apple Health file import wired; direct OAuth sync not yet connected | Partial |
Honest scope: the unified profile is built to ingest any health signal, with more added over time. The core streams are live in the demo (genetics, environment, surveys, lifestyle), with labs and wearables wired and awaiting a file or connection. Recommendations cite real retrieved literature today. On privacy: data is encrypted at rest under per-user keys with minimal retention today; minimization and pseudonymization before egress and a BAA-grade zero-retention inference endpoint are the near-term build; self-hosted inference and, far out, FHE are roadmap, not claimed as shipped. A clinical advisor joins ahead of the IRB validation study planned for 2027. The master key is still server-side today, and we state that plainly.
| Capability | Now (live MVP) | Target (this round and beyond) |
|---|---|---|
| Unified profile | Core streams live (genetics, environment, surveys, lifestyle) | More signals, deeper coverage, any health data |
| Privacy | Encrypted at rest, per-user keys, minimal retention | Minimization and pseudonymization before egress, BAA-grade zero-retention endpoint, on-device extraction; self-hosted inference and FHE on the roadmap |
| Key custody | Server-side master key | Device-bound (Secure Enclave) |
| Clinical validity | Synthetic demo model | Validated models, IRB study 2027 |
We show both columns on purpose. The left is what runs today; the right is what this round is built to deliver. We do not blur the two.
VitaCrypt is founder-led and deliberately capital-efficient: the working product was built end to end by Paul Burg, which keeps burn near zero while the hardest technical risk is retired first. Paul is a founder and operator who originates concepts and builds the product and the business around them: he first sketched VitaCrypt in San Francisco in 2019 and revived it when FHE matured, originated the tokenized real-world impact (tRWI) concept and built in the public-goods space. His training is in environmental engineering (a five-year specialist degree) with postgraduate research in ecology; longevity is the throughline. That breadth is why one person can scope the architecture, ship a working product and own delivery at this stage. This round turns a working product into a team. LinkedIn →
Owns the evidence engine and the unified-profile fabric: retrieval, grading, the three-tier router and anti-fabrication guards, and the source integrations that fuse signals into one profile. Staffed from month one. This is where the defensibility is built.
Wearables, genetics, microbiome and lab ingestion unified into one coherent profile.
Evidence-grading depth and validated-risk modeling, moving beyond associative readouts. The moat.
Plus a fractional independent security audit in place of a full cryptographer hire.
Security is covered by an independent audit (fractional) rather than a senior-cryptographer hire. Private compute and FHE are on the R&D roadmap, not a month-one central risk.
The roles are named because the plan is specific. The bet an early investor makes here is on a founder who knows exactly what the money buys, and in what order.
This is an early, founder-led round. Its shape is intentionally flexible at this stage; the goal is the right partner, not a fixed term sheet on a public page. Round size, the valuation cap and the financial model live in the deck and data room, shared on request.
The fastest way in is a short call and a look at the live product: a working demo with a fully populated profile is available to interested investors on request, granted personally. Request the deck and data room, or email investors@vitacrypt.xyz directly. We respond within 48 hours.